Search
for
Sort by
Community 61–90 of 187
- It's probably RU58841, which is weak in adenosine.
- PP405, a new hair growth stimulant that is completely different from minoxidil.
- [30M] 4 Months of Progress Oral 3MgMin&1.1MgFin + .5mm Derma Roller Mondays and Fridays
- 11 weeks post op !!!! What you think ?
- What do you think will be the next "big innovation" regarding AGA?
- To the late responders of finasteride. How long did it take to finally see results?
- NMN Promotes Cell Proliferation and Hair Growth by Reducing Oxidative Stress
- Physio-metabolic method (antiandrogen, minoxidil, leg training and cold)
- Would you continue to use Finasteride and Minoxidil once HMI 115 becomes available?
- If dutesteride and oral minoxidil doesn’t work that’s it right?
- Stop expecting results in 2 months!
- How much will GT20029 cost if it becomes FDA approved?
- Clascoterone study going on right now
- Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases
- GT20029 China Phase II Trial For AGA Reached Primary Endpoint
- How much would a high dose dutasteride scalp dht inhibition be?
- Has anyone ever tried using (all topicals) finasteride + minoxidil + rosemary oil + castor oil + stemoxydine all over the course of a few months/years?
- How to know if shedding is from tren or minoxidil?
- Is there any new drug that looks promising ?
- Creatine's effect on Hair Loss and DHT
- Is this broscience? From More Plates, More Dates
- 0.5mg Dutasteride promotes more “regrowth” than 5mg oral Minoxidil
- Finasteride vs Dutasteride, some helpfully info I put together as a physician
- Dutasteride SAVES your hair follicles: MAJOR BS on people who say it destroyed their hair permanently.
- Tried addressing DHT and regrowth, wanting to try additional path
- Can RU58841 stop hairloss for a long time?
- Pyrilutamide phase III clinical trial results released
- PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance
- I really hate how current hair loss treatment only rely on DHT blockers
- HMI-115 update: Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia